Correlation Between Mustang Bio and Sarepta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mustang Bio and Sarepta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mustang Bio and Sarepta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mustang Bio and Sarepta Therapeutics, you can compare the effects of market volatilities on Mustang Bio and Sarepta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mustang Bio with a short position of Sarepta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mustang Bio and Sarepta Therapeutics.
Diversification Opportunities for Mustang Bio and Sarepta Therapeutics
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Mustang and Sarepta is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Mustang Bio and Sarepta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarepta Therapeutics and Mustang Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mustang Bio are associated (or correlated) with Sarepta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarepta Therapeutics has no effect on the direction of Mustang Bio i.e., Mustang Bio and Sarepta Therapeutics go up and down completely randomly.
Pair Corralation between Mustang Bio and Sarepta Therapeutics
Given the investment horizon of 90 days Mustang Bio is expected to under-perform the Sarepta Therapeutics. In addition to that, Mustang Bio is 6.5 times more volatile than Sarepta Therapeutics. It trades about -0.12 of its total potential returns per unit of risk. Sarepta Therapeutics is currently generating about -0.06 per unit of volatility. If you would invest 12,066 in Sarepta Therapeutics on October 24, 2024 and sell it today you would lose (266.00) from holding Sarepta Therapeutics or give up 2.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mustang Bio vs. Sarepta Therapeutics
Performance |
| Timeline |
| Mustang Bio |
| Sarepta Therapeutics |
Mustang Bio and Sarepta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mustang Bio and Sarepta Therapeutics
The main advantage of trading using opposite Mustang Bio and Sarepta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mustang Bio position performs unexpectedly, Sarepta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarepta Therapeutics will offset losses from the drop in Sarepta Therapeutics' long position.| Mustang Bio vs. Checkpoint Therapeutics | Mustang Bio vs. Reviva Pharmaceuticals Holdings | Mustang Bio vs. Fortress Biotech Pref | Mustang Bio vs. Kodiak Sciences |
| Sarepta Therapeutics vs. Krystal Biotech | Sarepta Therapeutics vs. PTC Therapeutics | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |